AI vs. dermatologist for skin diagnosis
Part of Skin clinical trials.
This study tests whether an AI tool can help general practitioners diagnose skin conditions as accurately as a dermatologist. If you are an adult whose doctor already used OMNIDOC to send a skin image for expert review, you may be able to take part.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- Your general practitioner used the OMNIDOC system to send a request for a skin diagnosis.
- A dermatologist has already made a final diagnosis on your case.
- You must not object to having your health information shared with Social Security.
- Your skin image must be clear and usable for review.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well an AI system can diagnose retinal diseases from eye photos. It might help if you need a quick and accurate diagnosis using standard eye imaging.
This trial explores how AI and dermatologists can work together to better identify skin lesions. It aims to see if combining human expertise with AI guidance improves accuracy.
This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.
This trial compares two AI approaches to see which one helps doctors diagnose conditions better during remote patient interviews. It may help improve how AI assists healthcare providers.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This study tests a way for doctors to send clear images of your skin spot to be reviewed remotely using teledermoscopy (digital images of the skin). It may help speed up specialist input and improve how skin spots are assessed.
Hear when a new Skin Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.